Intermediates useful for making 2,4-pyrimidinediamine compounds

Details Intermediates useful for making 2,4-pyrimidinediamine compounds Intermediates useful for making 2,4-pyrimidinediamine compounds

2006-06-13

2006-06-13

Richter, Johann (Department: 1621)

Organic compounds -- part of the class 532-570 series

Organic compounds

Nitrogen attached directly or indirectly to the purine ring...

C544S324000, C544S320000

Reexamination Certificate

active

07060827

ABSTRACT:
The present invention provides 2,4-pyrimidinediamine compounds that inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators, intermediates and methods of synthesizing the compounds and methods of using the compounds in a variety of contexts, including in the treatment and prevention of diseases characterized by, caused by or associated with the release of chemical mediators via degranulation and other processes effected by activation of the IgE and/or IgG receptor signaling cascades.

REFERENCES:
patent: 4968781 (1990-11-01), Seitz et al.
patent: 2003/0165873 (2003-09-01), Come et al.
patent: 2004/0043388 (2004-03-01), Come et al.
patent: 2004/0122029 (2004-06-01), Liu et al.
patent: WO 03/018021 (2003-03-01), None
patent: WO 03/045923 (2003-06-01), None
patent: WO 03/063794 (2003-08-01), None
patent: WO 03/094920 (2003-11-01), None
patent: WO 2004/002964 (2004-01-01), None
patent: WO 2004/014382 (2004-02-01), None
patent: WO 2004/039359 (2004-05-01), None
patent: WO 2004/046118 (2004-06-01), None
patent: WO 2004/048343 (2004-06-01), None
patent: WO 2004/050068 (2004-06-01), None
patent: WO 2004/054617 (2004-07-01), None
patent: WO 2004/056786 (2004-07-01), None
patent: WO 2004/069812 (2004-08-01), None
patent: WO 2004/074244 (2004-09-01), None
patent: WO 2004/074261 (2004-09-01), None
patent: WO 2004/074262 (2004-09-01), None
patent: WO 2004/080980 (2004-09-01), None
Cores: An Automated Method for Generating Three-Dimensional Models of Protein/Ligand Complexes, Hare, Brian J., Journal of Chemistry (2004)47(19), 4731-4740.
Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC 125-R165335 (Etravirine) and related non-nucleoside reverse transcriptase inhibitors that are hightly potent and effective against wild-type and drug-resistant HIV-1variants. Das, Kalyan; Journal of Medicinal Chemistry (2004), 47(10), 2550-2560.
Identification of Compounds with Nanomoir binding Affinity for Checkpoint Kinase-1 Using Knowledge-Based Virtual Screening. Lyne, Pauld D.; Journal of Medicinal Chemistry (2004) 47(8), 1962-1968.

Affiliated with

Also associated with

Rating

Intermediates useful for making 2,4-pyrimidinediamine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intermediates useful for making 2,4-pyrimidinediamine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intermediates useful for making 2,4-pyrimidinediamine compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3708421